![Donald M. Crothers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Crothers is an outstanding scientist and successful entrepreneur who as has worked with Mr. Blume for over 20 years, actively assisting with investment decisions and filling key executive and advisory positions in portfolio companies.
He served as Chief Scientist at GeneOhm from its inception until its successful exit, guiding its platform development and IP strategy.
He is a member of the Scientific Advisory Board and Scientific Consultant at U.S.
Genomics, where he has been instrumental in solving technical challenges.
His advice was also critical in developing and strengthening the basic technology platforms in various portfolio companies including BioTrove, Exact Sciences, and Cytyc.
Dr. Crothers is Sterling Professor Emeritus and former Chairman of Chemistry at Yale University, and Professor Emeritus of Molecular Biophysics and Biochemistry and of Engineering at Yale.
He is a member of the National Academy of Sciences in recognition of his seminal work on DNA-protein interactions.
He has published more than 200 scientific papers, has 10 issued patents, and served on numerous advisory boards and committees.
Dr. Crothers received his BS from Yale University, BA from Cambridge University and PhD from UCSD.
| Sociétés | Poste | Fin |
|---|---|---|
Excel Medical Ventures LLC
 Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Directeur Technique/Scientifique/R&D | 09/12/2010 |
PathoGenetix, Inc.
 PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Directeur/Membre du Conseil | - |
CB Health Ventures
 CB Health Ventures Investment ManagersFinance CB Health Ventures focuses on investment opportunities in healthcare services, medical information technology, biotechnology and genomics | Private Equity Investor | - |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 7 |
|---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CB Health Ventures
CB Health Ventures Investment ManagersFinance CB Health Ventures focuses on investment opportunities in healthcare services, medical information technology, biotechnology and genomics | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Health Technology |
Excel Medical Ventures LLC
Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
